-
1
-
-
0036942527
-
Predictors of noncompliance in patients with schizophrenia
-
Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002;63:1121-1128. (Pubitemid 36084056)
-
(2002)
Journal of Clinical Psychiatry
, vol.63
, Issue.12
, pp. 1121-1128
-
-
Perkins, D.O.1
-
2
-
-
84856304513
-
Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia
-
Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH, et al. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia. Schizophr Res 2012;134:226-231.
-
(2012)
Schizophr Res
, vol.134
, pp. 226-231
-
-
Yang, J.1
Ko, Y.H.2
Paik, J.W.3
Lee, M.S.4
Han, C.5
Joe, S.H.6
-
3
-
-
78651342878
-
The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia
-
Glick ID, Stekoll AH, Hays S. The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia. J Clin Psychopharmacol 2011;31:82-85.
-
(2011)
J Clin Psychopharmacol
, vol.31
, pp. 82-85
-
-
Glick, I.D.1
Stekoll, A.H.2
Hays, S.3
-
4
-
-
33947223769
-
The case for long-acting antipsychotic agents in the post-CATIE era
-
DOI 10.1111/j.1600-0447.2006.00982.x
-
Nasrallah HA. The case for long-acting antipsychotic agents in the post-CATIE era. Acta Psychiatr Scand 2007;115:260-267. (Pubitemid 46425751)
-
(2007)
Acta Psychiatrica Scandinavica
, vol.115
, Issue.4
, pp. 260-267
-
-
Nasrallah, H.A.1
-
5
-
-
28944454252
-
A review of pharmacologic strategies for switching to atypical antipsychotics
-
Masand PS. A review of pharmacologic strategies for switching to atypical antipsychotics. Prim Care Companion J Clin Psychiatry 2005;7:121-129. (Pubitemid 41783228)
-
(2005)
Primary Care Companion to the Journal of Clinical Psychiatry
, vol.7
, Issue.3
, pp. 121-129
-
-
Masand, P.S.1
-
6
-
-
36849019910
-
Utilization of long-acting antipsychotic medication in patient care
-
Kane JM. Utilization of long-acting antipsychotic medication in patient care. CNS Spectr 2006;11(12 Suppl 14):1-7.
-
(2006)
CNS Spectr
, vol.11
, Issue.12 SUPPL. 14
, pp. 1-7
-
-
Kane, J.M.1
-
7
-
-
85012092311
-
Early intervention in psychosis: The critical period hypothesis
-
Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 1998;172:53-59. (Pubitemid 28258899)
-
(1998)
British Journal of Psychiatry
, vol.172
, Issue.JUNE AND SUPPL. 33
, pp. 53-59
-
-
Birchwood, M.1
Todd, P.2
Jackson, C.3
-
8
-
-
0027235574
-
Time course and biologic correlates of treatment response in first- episode schizophrenia
-
Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369-376. (Pubitemid 23143126)
-
(1993)
Archives of General Psychiatry
, vol.50
, Issue.5
, pp. 369-376
-
-
Lieberman, J.1
Jody, D.2
Geisler, S.3
Alvir, J.4
Loebel, A.5
Szymanski, S.6
Woerner, M.7
Borenstein, M.8
-
9
-
-
0035666578
-
The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches
-
DOI 10.1016/S0006-3223(01)01303-8, PII S0006322301013038
-
Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 2001;50:884-897. (Pubitemid 34023591)
-
(2001)
Biological Psychiatry
, vol.50
, Issue.11
, pp. 884-897
-
-
Lieberman, J.A.1
Perkins, D.2
Belger, A.3
Chakos, M.4
Jarskog, F.5
Boteva, K.6
Gilmore, J.7
-
10
-
-
13044268459
-
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
-
Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241-247. (Pubitemid 29125132)
-
(1999)
Archives of General Psychiatry
, vol.56
, Issue.3
, pp. 241-247
-
-
Robinson, D.1
Woerner, M.G.2
Alvir, J.Ma.J.3
Bilder, R.4
Goldman, R.5
Geisler, S.6
Koreen, A.7
Sheitman, B.8
Chakos, M.9
Mayerhoff, D.10
Lieberman, J.A.11
-
12
-
-
0025881660
-
Intermittent vs maintenance medication in schizophrenia. Two-year results
-
Herz MI, Glazer WM, Mostert MA, Sheard MA, Szymanski HV, Hafez H, et al. Intermittent vs maintenance medication in schizophrenia. Two-year results. Arch Gen Psychiatry 1991;48:333-339.
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 333-339
-
-
Herz, M.I.1
Glazer, W.M.2
Mostert, M.A.3
Sheard, M.A.4
Szymanski, H.V.5
Hafez, H.6
-
13
-
-
79951981601
-
Relapse prevention in first-episode schizophrenia - Maintenance vs intermittent drug treatment with prodrome-based early intervention: Results of a randomized controlled trial within the German Research Network on Schizophrenia
-
German Study Group on First-Episode Schizophrenia
-
Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, et al.; German Study Group on First-Episode Schizophrenia. Relapse prevention in first-episode schizophrenia - maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry 2011;72:205-218.
-
(2011)
J Clin Psychiatry
, vol.72
, pp. 205-218
-
-
Gaebel, W.1
Riesbeck, M.2
Wölwer, W.3
Klimke, A.4
Eickhoff, M.5
Von Wilmsdorff, M.6
-
14
-
-
72049091199
-
Attitudes towards long-acting depot antipsychotics: A survey of patients, relatives and psychiatrists
-
Jaeger M, Rossler W. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists. Psychiatry Res 2010;175:58-62.
-
(2010)
Psychiatry Res
, vol.175
, pp. 58-62
-
-
Jaeger, M.1
Rossler, W.2
-
15
-
-
0028911075
-
Depot neuroleptics in relapse prevention: Advantages and disadvantages
-
Gerlach J. Depot neuroleptics in relapse prevention: advantages and disadvantages. Int Clin Psychopharmacol 1995;9(Suppl 5):17-20.
-
(1995)
Int Clin Psychopharmacol
, vol.9
, Issue.SUPPL. 5
, pp. 17-20
-
-
Gerlach, J.1
-
16
-
-
4544241047
-
Early clinical experience with risperidone long-acting injection: A prospective, 6-month follow-up of 100 patients
-
Taylor DM, Young CL, Mace S, Patel MX. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients. J Clin Psychiatry 2004;65:1076-1083.
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 1076-1083
-
-
Taylor, D.M.1
Young, C.L.2
Mace, S.3
Patel, M.X.4
-
17
-
-
0038148672
-
Generating evidence to inform policy and practice: The example of the second generation "atypical" antipsychotics
-
Geddes J. Generating evidence to inform policy and practice: the example of the second generation "atypical" antipsychotics. Schizophr Bull 2003;29:105-114. (Pubitemid 36871061)
-
(2003)
Schizophrenia Bulletin
, vol.29
, Issue.1
, pp. 105-114
-
-
Geddes, J.1
-
18
-
-
77956575798
-
Long-acting injectable antipsychotics in the treatment of schizophrenia: Their role in relapse prevention
-
Agid O, Foussias G, Remington G. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention. Expert Opin Pharmacother 2010;11:2301-2317.
-
(2010)
Expert Opin Pharmacother
, vol.11
, pp. 2301-2317
-
-
Agid, O.1
Foussias, G.2
Remington, G.3
-
19
-
-
33748490089
-
Long-term treatment with long-acting risperidone in Korean patients with schizophrenia
-
Lee MS, Ko YH, Lee SH, Seo YJ, Kim SH, Joe SH, et al. Long-term treatment with long-acting risperidone in Korean patients with schizophrenia. Hum Psychopharmacol 2006;21:399-407.
-
(2006)
Hum Psychopharmacol
, vol.21
, pp. 399-407
-
-
Lee, M.S.1
Ko, Y.H.2
Lee, S.H.3
Seo, Y.J.4
Kim, S.H.5
Joe, S.H.6
-
20
-
-
58249142102
-
Oral versus injectable antipsychotic treatment in early psychosis: Post hoc comparison of two studies
-
Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Clin Ther 2008;30:2378-2386.
-
(2008)
Clin Ther
, vol.30
, pp. 2378-2386
-
-
Emsley, R.1
Oosthuizen, P.2
Koen, L.3
Niehaus, D.J.4
Medori, R.5
Rabinowitz, J.6
-
21
-
-
70350167140
-
Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: The SPHERE Study
-
De la Gándara J, San Molina L, Rubio G, Rodriguez-Morales A, Hidalgo Borrajo R, Burón JA. Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study. Expert Rev Neurother 2009;9:1463-1474.
-
(2009)
Expert Rev Neurother
, vol.9
, pp. 1463-1474
-
-
De La Gándara, J.1
San Molina, L.2
Rubio, G.3
Rodriguez-Morales, A.4
Borrajo, R.H.5
Burón, J.A.6
-
22
-
-
34247367267
-
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia
-
DOI 10.1176/appi.ps.58.4.482
-
Shi L, Ascher-Svanum H, Zhu B, Faries D, Montgomery W, Marder SR. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatr Serv 2007;58:482-488. (Pubitemid 46640638)
-
(2007)
Psychiatric Services
, vol.58
, Issue.4
, pp. 482-488
-
-
Shi, L.1
Ascher-Svanum, H.2
Zhu, B.3
Faries, D.4
Montgomery, W.5
Marder, S.R.6
-
23
-
-
0346665571
-
Use of antipsychotic medications in Australia between July 1995 and December 2001
-
DOI 10.1046/j.1440-1614.2003.01110.x
-
Mond J, Morice R, Owen C, Korten A. Use of antipsychotic medications in Australia between July 1995 and December 2001. Aust N Z J Psychiatry 2003;37:55-61. (Pubitemid 36395329)
-
(2003)
Australian and New Zealand Journal of Psychiatry
, vol.37
, Issue.1
, pp. 55-61
-
-
Mond, J.1
Morice, R.2
Owen, C.3
Korten, A.4
-
24
-
-
33845998909
-
Attitudes of psychiatrists toward antipsychotic depot medication
-
Heres S, Hamann J, Kissling W, Leucht S. Attitudes of psychiatrists toward antipsychotic depot medication. J Clin Psychiatry 2006;67:1948-1953. (Pubitemid 46048193)
-
(2006)
Journal of Clinical Psychiatry
, vol.67
, Issue.12
, pp. 1948-1953
-
-
Heres, S.1
Hamann, J.2
Kissling, W.3
Leucht, S.4
-
25
-
-
33747185865
-
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: Observational follow-up study
-
Tiihonen J, Wahlbeck K, Lönnqvist J, Klaukka T, Ioannidis JP, Volavka J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006;333:224.
-
(2006)
BMJ
, vol.333
, pp. 224
-
-
Tiihonen, J.1
Wahlbeck, K.2
Lönnqvist, J.3
Klaukka, T.4
Ioannidis, J.P.5
Volavka, J.6
-
26
-
-
0020068603
-
Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia
-
Kane JM, Rifkin A, Quitkin F, Nayak D, Ramos-Lorenzi J. Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatry 1982;39:70-73. (Pubitemid 12163378)
-
(1982)
Archives of General Psychiatry
, vol.39
, Issue.1
, pp. 70-73
-
-
Kane, J.M.1
Rifkin, A.2
Quitkin, F.3
-
27
-
-
41049103316
-
Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: A preliminary study
-
DOI 10.1097/JCP.0b013e318167269d, PII 0000471420080400000012
-
Emsley R, Medori R, Koen L, Oosthuizen PP, Niehaus DJ, Rabinowitz J. Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study. J Clin Psychopharmacol 2008;28:210-213. (Pubitemid 351419182)
-
(2008)
Journal of Clinical Psychopharmacology
, vol.28
, Issue.2
, pp. 210-213
-
-
Emsley, R.1
Medori, R.2
Koen, L.3
Oosthuizen, P.P.4
Niehaus, D.J.H.5
Rabinowitz, J.6
-
28
-
-
55849131073
-
Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: A study with risperidone long-acting injection
-
Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Int Clin Psychopharmacol 2008;23:325-331.
-
(2008)
Int Clin Psychopharmacol
, vol.23
, pp. 325-331
-
-
Emsley, R.1
Oosthuizen, P.2
Koen, L.3
Niehaus, D.J.4
Medori, R.5
Rabinowitz, J.6
-
29
-
-
49849092027
-
Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
-
Kim B, Lee SH, Choi TK, Suh S, Kim YW, Lee E, et al. Effectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic setting. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1231-1235.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 1231-1235
-
-
Kim, B.1
Lee, S.H.2
Choi, T.K.3
Suh, S.4
Kim, Y.W.5
Lee, E.6
-
30
-
-
72849116914
-
A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: Initial adherence outcome
-
Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. J Clin Psychiatry 2009;70:1397-1406.
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 1397-1406
-
-
Weiden, P.J.1
Schooler, N.R.2
Weedon, J.C.3
Elmouchtari, A.4
Sunakawa, A.5
Goldfinger, S.M.6
-
31
-
-
80052438410
-
Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory
-
Bartzokis G, Lu PH, Amar CP, Raven EP, Detore NR, Altshuler LL, et al. Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. Schizophr Res 2011;132:35-41.
-
(2011)
Schizophr Res
, vol.132
, pp. 35-41
-
-
Bartzokis, G.1
Lu, P.H.2
Amar, C.P.3
Raven, E.P.4
Detore, N.R.5
Altshuler, L.L.6
-
32
-
-
0347416713
-
Long-Acting Injectable Antipsychotics in the Elderly: Guidelines for Effective Use
-
DOI 10.2165/00002512-200320150-00003
-
Masand PS, Gupta S. Long-acting injectable antipsychotics in the elderly: guidelines for effective use. Drugs Aging 2003;20:1099-1110. (Pubitemid 38041351)
-
(2003)
Drugs and Aging
, vol.20
, Issue.15
, pp. 1099-1110
-
-
Masand, P.S.1
Gupta, S.2
-
33
-
-
0034073574
-
Side effects of antipsychotics in the elderly
-
Masand PS. Side effects of antipsychotics in the elderly. J Clin Psychiatry 2000;61(Suppl 8):43-49.
-
(2000)
J Clin Psychiatry
, vol.61
, Issue.SUPPL. 8
, pp. 43-49
-
-
Masand, P.S.1
|